The pharmaceutical company honcho who sparked outrage by gouging the price of a lifesaving HIV drug has been revealed to be the buyer of the only copy of the new Wu Tang Clan album, “One Upon a Time in Shaolin.”
Martin Shkreli was the highest bidder for the 31-track album by the Staten Island-based hip hop ensemble, Bloomberg News reported.
And Shkreli, who was publicly pilloried when it was revealed that he planned to increase the price of Daraprim by 5,000 percent, spent $2 million for the record, according to Bloomberg, which cited “someone familiar with the deal” as its source.
The album includes a single called C.R.E.A.M., which stands for “Cash Rules Everything Around Me,” and which features the oft-repeated phrase “Dolla dolla bill, y’all!”
Shkreli was vilified in September after his company, Turing Pharmaceuticals of New York, bought the rights to the drug from Impax Laboratories for $55 million — and raised the price from $13.50 to $750 per pill.
Daraprim fights toxoplasmosis, an infection that is especially dangerous for AIDS patients with weakened immune systems and also pregnant women, according to the Centers for Disease Control and Prevention.
RELATED: Company offers $1 alternative to Pharma Bro’s drug
Shkreli defended the price hike on a drug that has been around for 62 years — and can be purchased in Europe for about a buck a pill.
“It’s very easy to see a large drug price increase and say ‘Gosh, those people must be gouging,” he told NBC News. “But when you find out that the company is not really making any money, what does that mean? It’s very hard stuff to understand.”
Corky Siemaszko









